Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial.

Autor: Gruner M; Gastroenterology Division, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France., Denis A; Pole de Santé Publique, Statistics and Medical Research Department, Hospices Civils de Lyon, Lyon, France., Masliah C; Gastroenterology Division, Clinique Mutualiste de l'Estuaire, Saint Nazaire, France., Amil M; Gastroenterology Division, Centre Hospitalier Départemental Les Oudairies, La Roche sur Yon, France., Metivier-Cesbron E; Gastroenterology Division, Centre Hospitalo-Universitaire Larrey, Angers, France., Luet D; Gastroenterology Division, Centre Hospitalo-Universitaire Larrey, Angers, France., Kaasis M; Gastroenterology Division, Centre Hospitalier de Cholet, Cholet, France., Coron E; Hepatogastroenterology Department, Hotel Dieu, Nantes, France., Le Rhun M; Hepatogastroenterology Department, Hotel Dieu, Nantes, France., Lecleire S; Gastroenterology Division, Hôpital Charles Nicolle, Centre Hospitalo-Universitaire, Rouen, France., Antonietti M; Gastroenterology Division, Hôpital Charles Nicolle, Centre Hospitalo-Universitaire, Rouen, France., Legoux JL; Gastroenterology Division, Hôpital La Source, Centre Hospitalier Régional, Orléans, France., Lefrou L; Gastroenterology Division, Hôpital La Source, Centre Hospitalier Régional, Orléans, France., Renkes P; Gastroenterology Division, Hôpital Clinique Claude Bernard, Metz, France., Tarreirias AL; Gastroenterology Division, Hôpital Foch, Suresnes, France., Balian P; Gastroenterology Division, Hôpital Foch, Suresnes, France., Rey P; Gastroenterology Division, Hôpital d'Instruction des Armées, Legouest, Metz, France., Prost B; Gastroenterology Division, Centre Hospitalier Saint Joseph Saint Luc, Lyon, France., Cellier C; Gastroenterology Division, Hôpital Européen Georges Pompidou, Paris, France., Rahmi G; Gastroenterology Division, Hôpital Européen Georges Pompidou, Paris, France., Samaha E; Gastroenterology Division, Hôpital Européen Georges Pompidou, Paris, France., Fratte S; Gastroenterology Division, Centre Hospitalier Régional, Belfort, France., Guerrier B; Gastroenterology Division, Centre Hospitalier Bourg en Bresse, Bourg en Bresse, France., Landel V; Direction Recherche Clinique et Innovations, Hospices Civils de Lyon, Lyon, France., Touzet S; Pole de Santé Publique, Statistics and Medical Research Department, Hospices Civils de Lyon, Lyon, France., Ponchon T; Gastroenterology Division, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.; Lyon 1 University Claude Bernard, Lyon, France.; INSERM U1032, LabTAU, Lyon, France., Pioche M; Gastroenterology Division, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.; Lyon 1 University Claude Bernard, Lyon, France.; INSERM U1032, LabTAU, Lyon, France.

Publikováno v: Endoscopy [Endoscopy] 2021 Jul; Vol. 53 (7), pp. 674-682. Date of Electronic Publication: 2020 Oct 01.

Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatremia - a randomized, double-blind, placebo-controlled study

Autor: Ginès P, Wong F, Watson H, Terg R, Bruha R, Zarski JP, Dudley F, NormoCAT study investigators: Angeli P, Angus P, Bilic A, Bronowicki JP, Chira C, Dobru D, Doffoel M, Fleig W, Fraticiu A, Gadano A, Gerbes A, Gheorge L, Goldis A, Grigorescu M, Horsmans Y, Hulek P, Lata J, Lonovics J, Manns M, Masliah C, Morichaut Beauchant M, Olteanu D, Pascu O, Planas R, Ramdani M, Ruiz del Arbol L, Siahmed SN, Stoica V, Ujszaszy L, Voiosu M.R., BERNARDI, MAURO

Publikováno v: Alimentary Pharmacology & Therapeutics.

Aliment Pharmacol Ther 31, 834–845 Summary Background There is little information on the effects of vaptans in patients with cirrhosis. Aim To investigate the short-term effects of satavaptan, a selective vasopressin V2 receptor antagonist on ascit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2482f917f081ca00935871e08da25a74
https://doi.org/10.1111/j.1365-2036.2010.04236.x

DOSE INTENSITY AND TOLERANCE IMPROVEMENT OF CETUXIMAB, IRINOTECAN, 5-FU AND FOLINIC ACID IN PATIENTS WITH METASTATIC CRC; A PHARMACOKINETIC AND PHARMACOGENETIC APPROACH

Autor: Gamelin, E., Metges, J., Adenis, Antoine, Raoul, Jean-Luc, Lam, Y., Lecomte, T., Faroux, R., Luet, D., Masliah, C., Berger, V.

Publikováno v: Annals of Oncology
Annals of Oncology, Elsevier, 2008, 19, pp.131-131
Annals of Oncology, 2008, 19, pp.131-131

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::515c536bdcd6b7e2e38f081204410fa3
https://hal.archives-ouvertes.fr/hal-00618341

Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma.

Autor: Merle P; Hepatology Unit, Groupement Hospitalier Lyon Nord, Lyon, France., Camus P; Centre Hospitalier Universitaire de Dijon, Dijon, France., Abergel A; Hepato-Gastroenterology Unit, Hôtel Dieu, Clermont-Ferrand, France., Pageaux GP; Hôpital St Eloi, Montpellier, France., Masliah C; Hôtel Dieu, Nantes, France., Bronowicki JP; Hôpital Brabois, Vandoeuvre-Les-Nancy, France., Zarski JP; Hôpital Michallon, Grenoble, France., Pelletier G; Hôpital Paul Brousse, Villejuif, France., Bouattour M; Beaujon Hospital, Clichy, France., Farloux L; Hôpital Saint-Antoine, Paris, France., Dorval E; Hôpital Trousseau, Chambray-Les-Tours, France., Verset G; Hôpital Erasme, Brussels, Belgium., Si-Ahmed SN; Hôpital La Source, Orléans, France., Doffoel M; Hôpital Civil, Strasbourg, France., Couzigou P; Hôpital Haut-Leveque, Pessac, France., Taieb J; Hopital La Pitié Salpétrière, Paris, France., Vasseur B; Onxeo, Paris, France., Attali P; Onxeo, Paris, France.

Publikováno v: ESMO open [ESMO Open] 2017 Oct 23; Vol. 2 (4), pp. e000238. Date of Electronic Publication: 2017 Oct 23 (Print Publication: 2017).

PD-0007 - A Triple Combination Tailored Therapy (Folfiri-Cetuximab) for Safe Dose Intensification: A Multicenter Phase II Proof-Of-Concept Study.

Autor: Capitain, O., Metges, J.P., Boisdron-Celle, M., Adenis, A., Raoul, J.L., Lecomte, T., Lam, Y., Faroux, R., Masliah, C., Poirier, A.L., Berger, V., Morel, A., Gamelin, E.

Publikováno v: In Annals of Oncology June 2014 25 Supplement 2:ii7-ii7